Anteris Technologies Global Corp. (ASX:AVR)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Anti-calcification Tissue Shaping Technology	2.70M
Anti-calcification Tissue Shaping Technology Growth	-1.16%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	1.78M
United States Growth	-20.98%
Germany	900.00K
Germany Growth	90.97%
Australia	21.00K
Australia Growth	148.90%